Stocks That Fell to 3-Year Lows in the Week of Dec. 15
- By Shuda Xia
General Electric Co. (GE), GlaxoSmithKline PLC (GSK), Ferrellgas Partners LP (FGP) and Crescent Point Energy Corp. (CPG) have declined to their three-year lows.
General Electric Co. (GE) declined to $17.82
The prices of General Electric Co. (GE) shares have declined to $17.82 on Dec. 15, which is only 2.0% above the 3-year low of $17.46.
Warning! GuruFocus has detected 4 Warning Signs with GE. Click here to check it out.
The intrinsic value of GE
General Electric Co. is an American international conglomerate corporation and operates through multiple segments, including Power & Water, Oil and Gas, Aviation, Healthcare, and Transportation. The company has over 305,000 employees as of 2015 and ranked among the Fortune 500 as the 4th largest firm in the United States as of 2017.
General Electric Co. has a market cap of $154.54 billion; its shares were traded around $17.82 with a P/E ratio of 22.56 and P/S ratio of 1.26. The trailing 12-month dividend yield of General Electric Co. stocks is 5.38%. The forward dividend yield of General Electric Co. stocks is 4.76%.
On Dec. 13 General Electric Co. announced agreements to provide 270 MW of wind energy capacity to Wind Energy Holding, a member of Thailand"s KPN Group, for the Theparak Wind Farm in central Thailand. The electricity generated is enough to power the equivalent of more than 120,000 local homes. General Electric Co. is set to provide a total of ninety 3.0-137 wind turbines with 156.5m hybrid towers, making those the tallest turbines the company has installed outside of Europe.
GlaxoSmithKline PLC (GSK) declined to $34.99
The prices of GlaxoSmithKline PLC (GSK) shares have declined to $34.99 on Dec. 15, which is only 1.2% above the 3-year low of $34.58.
GlaxoSmithKline PLC is a British pharmaceutical company formed from the merger of Glaxo Wellcome and SmithKline Beecham in 2000. In 2015 it was the world"s sixth largest pharmaceutical company. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. Some of its top selling products include Advair, Avodart, Augmentin, Lovaza and Flovent.
GlaxoSmithKline PLC has a market cap of $83.77 billion; its shares were traded around $34.99 with a P/E ratio of 27.34 and P/S ratio of 2.09. The trailing 12-month dividend yield of GlaxoSmithKline PLC stocks is 5.92%. The forward dividend yield of GlaxoSmithKline PLC stocks is 5.72%.
On Dec. 14 GlaxoSmithKline PLC announced the submission of a regulatory application to the Australian Therapeutics Good Administration seeking approval of single-dose tafenoquine treatment for radical cure, or prevention of relapse, of malaria. Approval of tafenoquine by the TGA will help facilitate registrations in countries where malaria is endemic.
Ferrellgas Partners LP (FGP) declined to $4.10
The prices of Ferrellgas Partners LP (FGP) shares have declined to $4.10 on Dec. 15, which is only 0.0% above the 3-year low of $4.10.
Ferrellgas Partners L.P. is an American supplier of propane. The company has corporate operations in the Kansas City suburbs of Liberty, Missouri and Overland Park, Kansas. As of September 2016, the company has 911 retail locations in all 50 states and the District of Columbia in addition to locations in Puerto Rico.
Ferrellgas Partners LP has a market cap of $398.310 million; its shares were traded around $4.10 with and P/S ratio of 0.20. The trailing 12-month dividend yield of Ferrellgas Partners LP stocks is 9.75%. The forward dividend yield of Ferrellgas Partners LP stocks is 9.48%.
On Dec. 7 Ferrellgas Partners LP reported financial results for the first quarter of fiscal 2018 ended Oct. 31, 2017. Net loss was $47.9 million, or $0.49 per common unit, compared to net loss of $43.1 million, or $0.44 per common unit, for the same period prior year. Total gallons sold in the first quarter increased more than 9.5 million gallons over the same period in the prior year, partially offsetting the effects of lower margins as the company aggressively competes for a larger consumer base.
Crescent Point Energy Corp. (CPG) declined to $6.43
The prices of Crescent Point Energy Corp. (CPG) shares have declined to $6.43 on Dec. 15, which is only 0.2% above the 3-year low of $6.42.
Crescent Point Energy Corp. is a Canadian international oil and gas company that focuses primarily on light oil production in southern Saskatchewan and the Uinta basin in Utah. The company is one of Canada"s largest oil and gas producers. The company"s business strategy includes developing and enhancing its asset base by increasing recovery factors through infill drilling and by acquiring high quality large oil in place pools.
Crescent Point Energy Corp. has a market cap of $3.52 billion; its shares were traded around $6.43 with and P/S ratio of 1.48. The trailing 12-month dividend yield of Crescent Point Energy Corp. stocks is 4.32%. The forward dividend yield of Crescent Point Energy Corp. stocks is 4.20%. Crescent Point Energy Corp. had an annual average earnings growth of 0.70% over the past 10 years.
On Dec. 15 Crescent Point Energy Corp. announced that its Board of Directors has declared a dividend of CDN$0.03 per share payable on Jan. 15, 2018, to shareholders of record at the close of business on Dec. 31, 2017.
Disclosure: I do not own stock in any of the companies mentioned in the article.
This article first appeared on GuruFocus.
Warning! GuruFocus has detected 4 Warning Signs with GE. Click here to check it out.
The intrinsic value of GE
